DE PLACIDO, SABINO
DE PLACIDO, SABINO
DIPARTIMENTO DI SANITA' PUBBLICA
Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy.
2004 Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G.
Phase II study of mitomycin C, etopside and vindesine (MEV) in metastatic, stage IV, non small cell lung cancer.
1991 Gridelli, C.; Pepe, R.; Palmeri, S.; Iacobelli, S.; Gentile, M.; Gebbia, V.; Garufi, C.; Airoma, G.; Palmieri, Giovannella; Russo, A.; Incoronato, P.; DE PLACIDO, Sabino; Perrone, F.; Basilico, L.; Rausa, L.; Ferrante, G.; Bianco, ANGELO RAFFAELE
The treatment of metastatic pleural effusion in breast cancer: report of 25 cases.
1987 Contegiacomo, Alma; L., Fiorillo; DE PLACIDO, Sabino; C., Pagliarulo; Iaffaioli, ROSARIO VINCENZO; G., Genua; F., Giampaglia; Palmieri, Giovannella; A. R., Bianco
A comprehensive outlook on inracerebral therapy of malignant gliomas
2010 Buonerba, Carlo; Di lorenzo, G.; Marinelli, Alfredo; Federico, Piera; Palmieri, Giovannella; Imbimbo, Martina; Conti, P.; Peluso, G.; DE PLACIDO, Sabino; Sampson, J. H.
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?
2010 Gallo, C.; Buonerba, Carlo; Di Lorenzo, G.; Romeo, V.; DE PLACIDO, Sabino; Marinelli, Alfredo
COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER.
2004 Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora
Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast
2010 Early Breast Cancer Trialists' Collaborative, Group; Correa, C.; Mcgale, P.; Taylor, C.; Wang, Y.; Clarke, M.; Davies, C.; Peto, R.; Bijker, N.; Solin, L.; Darby, S.; DE PLACIDO, Sabino
EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS IN LATE STAGE CLINICAL TRIALS (REVIEW).
2003 Ciardiello, F; DE VITA, F; Orditura, M; DE PLACIDO, Sabino; Tortora, G.
Adrenalectomy: defining its role in thr surgical treatment of renal cell carcinoma
2003 DE SIO, M; Autorino, R; DI LORENZO, G; Damiano, R; Cosentino, L; DE PLACIDO, Sabino; Armiento, M.
Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide.
2000 Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello,
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225.
1999 Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo
Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma.
2005 Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo
Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
2001 Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives.
2003 Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M.
Quality of Life of Postmenopausal the Women in the Arimidex, Tamoxifen, alone or in combination (ATAC)Adjuvant breast Cancer Trial.
2004 Fallowfield, L.; Cella, D.; Cuzick, J.; Francis, S.; Locker, G.; Howell, A.; DE PLACIDO, Sabino
Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMa).
1996 Giordano, Lara; Giorgi, D.; Fasolo, G.; Segnan, N.; Rosselli Del Turco, M.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino; Sodano, Antonio; Pini, M. T.; Nuzzo, F.; Perrone, F.
Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study.
2008 DI LORENZO, Giuseppe; Di Trolio, R; Montesarchio, V; Palmieri, Giovannella; Nappa, P; Delfino, Mario; DE PLACIDO, Sabino; Dezube, B. J.
Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients.
2009 Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, Nicola; Imbimbo, C; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino
Castration-resistant prostate cancer: current and emerging treatment strategies
2010 Di Lorenzo, G.; Buonerba, Carlo; Autorino, Riccardo; DE PLACIDO, Sabino; Strernberg, C. N.
Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients.
2010 Leopardo, D.; Di Lorenzo, G.; DE RENZO, Amalia; Federico, Piera; Luponio, S.; Buonerba, Carlo; Matano, Elide; Merola, G.; Imbimbo, Martina; Montesarchio, E.; Rea, A.; Meroca, M. C.; DE PLACIDO, Sabino; Palmieri, Giovannella
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Antitumor activity of ZD6474, a vascular endothelial growth factor receptor tyrosine kinase inhibitor, in human cancer cells with acquired resistance to antiepidermal growth factor receptor therapy. | 1.1 Articolo in rivista | 2004 | Ciardiello, F; Bianco, Roberto; Caputo, R; Caputo, R; Damiano, Vincenzo; Troiani, T; Melisi, D; DE VITA, F; DE PLACIDO, Sabino; Bianco, Ar; Tortora, G. | |
| Phase II study of mitomycin C, etopside and vindesine (MEV) in metastatic, stage IV, non small cell lung cancer. | 1.1 Articolo in rivista | 1991 | Gridelli, C.; Pepe, R.; Palmeri, S.; Iacobelli, S.; Gentile, M.; Gebbia, V.; Garufi, C.; Airoma, G.; Palmieri, Giovannella; Russo, A.; Incoronato, P.; DE PLACIDO, Sabino; Perrone, F.; Basilico, L.; Rausa, L.; Ferrante, G.; Bianco, ANGELO RAFFAELE | |
| The treatment of metastatic pleural effusion in breast cancer: report of 25 cases. | 1.1 Articolo in rivista | 1987 | Contegiacomo, Alma; L., Fiorillo; DE PLACIDO, Sabino; C., Pagliarulo; Iaffaioli, ROSARIO VINCENZO; G., Genua; F., Giampaglia; Palmieri, Giovannella; A. R., Bianco | |
| A comprehensive outlook on inracerebral therapy of malignant gliomas | 1.1 Articolo in rivista | 2010 | Buonerba, Carlo; Di lorenzo, G.; Marinelli, Alfredo; Federico, Piera; Palmieri, Giovannella; Imbimbo, Martina; Conti, P.; Peluso, G.; DE PLACIDO, Sabino; Sampson, J. H. | |
| Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme? | 1.1 Articolo in rivista | 2010 | Gallo, C.; Buonerba, Carlo; Di Lorenzo, G.; Romeo, V.; DE PLACIDO, Sabino; Marinelli, Alfredo | |
| COMBINED TARGETING OF EGFR AND MDM2 BY GEFITINIB AND ANTISENSE MDM2 COOPERATIVELY INHIBIT HORMONE-INDEPENDENT PROSTATE CANCER. | 1.1 Articolo in rivista | 2004 | Bianco, Roberto; Caputo, R; Caputo, R; Damiano, V; DE PLACIDO, Sabino; Ficorella, C; Agrawal, S; Bianco, Ar; Ciardiello, F; G., Tortora | |
| Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast | 1.1 Articolo in rivista | 2010 | Early Breast Cancer Trialists' Collaborative, Group; Correa, C.; Mcgale, P.; Taylor, C.; Wang, Y.; Clarke, M.; Davies, C.; Peto, R.; Bijker, N.; Solin, L.; Darby, S.; DE PLACIDO, Sabino | |
| EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) TYROSINE KINASE INHIBITORS IN LATE STAGE CLINICAL TRIALS (REVIEW). | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | Ciardiello, F; DE VITA, F; Orditura, M; DE PLACIDO, Sabino; Tortora, G. | |
| Adrenalectomy: defining its role in thr surgical treatment of renal cell carcinoma | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | DE SIO, M; Autorino, R; DI LORENZO, G; Damiano, R; Cosentino, L; DE PLACIDO, Sabino; Armiento, M. | |
| Antitumor activity of combined treatment of human cancer cells with ionizing radiations and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. | 1.1 Articolo in rivista | 2000 | Bianco, C; Bianco, Roberto; Tortora, Giampaolo; Damiano, Vincenzo; Guerrieri, P; Montemaggi, P; Mendelsohn, J; DE PLACIDO, Sabino; Bianco, Ar; Ciardiello, | |
| Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. | 1.1 Articolo in rivista | 1999 | Ciardiello, F; Bianco, Roberto; Damiano, Vincenzo; DE LORENZO, Sonya; Pepe, Stefano; DE PLACIDO, Sabino; Fan, Z; Mendelsohn, J; Bianco, A. R.; Tortora, Giampaolo | |
| Cooperative antitumor effect of multitargeted kinase inhibitor ZD6474 and ionizing radiation in glioblastoma. | 1.1 Articolo in rivista | 2005 | Damiano, V; Melisi, D; Bianco, C; Raben, D; Caputo, R; Fontanini, G; Bianco, Roberto; Ryan, A; Bianco, Ar; DE PLACIDO, Sabino; Ciardiello, F; Tortora, Giampaolo | |
| Inhibition of growth factors production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. | 1.1 Articolo in rivista | 2001 | Ciardiello, F; Caputo, R; Bianco, Roberto; Damiano, Vincenzo; Fontanini, G; Cuccato, S; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| Role of chemotherapy in hormone – refractory prostate cancer. Old issues, recent advances and new perspectives. | 2.1 Contributo in volume (Capitolo o Saggio) | 2003 | Autorino, R; DI LORENZO, G; Damiano, R; DE PLACIDO, Sabino; Darmiento, M. | |
| Quality of Life of Postmenopausal the Women in the Arimidex, Tamoxifen, alone or in combination (ATAC)Adjuvant breast Cancer Trial. | 1.1 Articolo in rivista | 2004 | Fallowfield, L.; Cella, D.; Cuzick, J.; Francis, S.; Locker, G.; Howell, A.; DE PLACIDO, Sabino | |
| Breast cancer screening: characteristics and results of the Italian programmes in the Italian group for planning and evaluating breast cancer screening programmes (GISMa). | 1.1 Articolo in rivista | 1996 | Giordano, Lara; Giorgi, D.; Fasolo, G.; Segnan, N.; Rosselli Del Turco, M.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino; Sodano, Antonio; Pini, M. T.; Nuzzo, F.; Perrone, F. | |
| Pegylated liposomal doxorubicin as second-line therapy in the treatment of patients with advanced classic Kaposi sarcoma: a retrospective study. | 1.1 Articolo in rivista | 2008 | DI LORENZO, Giuseppe; Di Trolio, R; Montesarchio, V; Palmieri, Giovannella; Nappa, P; Delfino, Mario; DE PLACIDO, Sabino; Dezube, B. J. | |
| Phase 1/2 study of intravenous paclitaxel and oral cyclophosphamide in pretreated metastatic urothelial bladder cancer patients. | 1.1 Articolo in rivista | 2009 | Di Lorenzo, G; Montesarchio, V; Autorino, R; Bellelli, T; Longo, Nicola; Imbimbo, C; Morelli, E; Giannarini, G; Mirone, Vincenzo; DE PLACIDO, Sabino | |
| Castration-resistant prostate cancer: current and emerging treatment strategies | 1.1 Articolo in rivista | 2010 | Di Lorenzo, G.; Buonerba, Carlo; Autorino, Riccardo; DE PLACIDO, Sabino; Strernberg, C. N. | |
| Efficacy of rituximab in gastric diffuse large B cell Lymphoma patients. | 1.1 Articolo in rivista | 2010 | Leopardo, D.; Di Lorenzo, G.; DE RENZO, Amalia; Federico, Piera; Luponio, S.; Buonerba, Carlo; Matano, Elide; Merola, G.; Imbimbo, Martina; Montesarchio, E.; Rea, A.; Meroca, M. C.; DE PLACIDO, Sabino; Palmieri, Giovannella |